Large-scale testing (Phase 3)Study completedNCT02526160What this trial is testingStudy of KRN23 in Adults With X-linked Hypophosphatemia (XLH)Who this might be right forX-linked Hypophosphatemia Kyowa Kirin, Inc. 134
Early research (Phase 1)Study completedNCT00830674What this trial is testingKRN23 in X-linked HypophosphatemiaWho this might be right forX-linked Hypophosphatemia Kyowa Kirin Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06525636What this trial is testingA First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaWho this might be right forX-linked Hypophosphatemia Kyowa Kirin Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT02312687What this trial is testingLong-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)Who this might be right forX-Linked Hypophosphatemia Kyowa Kirin, Inc. 20
Post-approval studies (Phase 4)Study completedNCT04146935What this trial is testingExamining the Effect of Burosumab on Muscle FunctionWho this might be right forX-linked Hypophosphatemia Yale University 10
Large-scale testing (Phase 3)Study completedNCT02537431What this trial is testingOpen Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)Who this might be right forX-linked Hypophosphatemia Kyowa Kirin, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT01571596What this trial is testingAn Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaWho this might be right forX-linked Hypophosphatemia Kyowa Kirin Co., Ltd. 23
Large-scale testing (Phase 3)Study completedNCT02915705What this trial is testingEfficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLHWho this might be right forX-Linked Hypophosphatemia Kyowa Kirin, Inc. 61
Not applicableLooking for participantsNCT07183579What this trial is testingEffective Dosing of Burosumab in XLHWho this might be right forX-linked Hypophosphatemia (XLH) University of Nottingham 120
Testing effectiveness (Phase 2)Study completedNCT02720770What this trial is testingGrowth Hormone Treatment in Children With Hypophosphatemic RicketsWho this might be right forX Linked Hypophosphatemic Rickets Bicetre Hospital 19
Post-approval studies (Phase 4)UnknownNCT04419363What this trial is testingBurosumab in Children and Adolescents With X-linked HypophosphatemiaWho this might be right forRare DiseasesX-linked Hypophosphatemia Bicetre Hospital 57
Testing effectiveness (Phase 2)Study completedNCT02750618What this trial is testingStudy of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)Who this might be right forX-Linked Hypophosphatemia Kyowa Kirin, Inc. 13
Not applicableStudy completedNCT04273490What this trial is testingCharacterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy ControlsWho this might be right forX-linked HypophosphatemiaHereditary Hypophosphatemia University of Aarhus 92
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT02163577What this trial is testingStudy of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)Who this might be right forX-linked Hypophosphatemia Kyowa Kirin, Inc. 52
Not applicableStudy completedNCT04819490What this trial is testingA UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLHWho this might be right forX-Linked Hypophosphataemia Kyowa Kirin Pharmaceutical Development Ltd 32
Early research (Phase 1)UnknownNCT00473187What this trial is testingEffects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic RicketsWho this might be right forHypophosphatemic RicketsGrowth DisordersSomatropin Therapy University of Rostock
Not applicableStudy completedNCT03489993What this trial is testingFGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)Who this might be right forHypophosphatemiaX-linked HypophosphatemiaRenin-angiotensin System+1 more Wake Forest University Health Sciences 8
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Post-approval studies (Phase 4)Study completedNCT04842019What this trial is testingStudy to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLHWho this might be right forX-linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd. 18